SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3igo'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DTL_A_BEPA204_1 (CARDIAC TROPONIN C)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 11	ILE A 186 LEU A 199 LEU A 160 LEU A 268 LEU A 267	None	1.05A	1dtlA-3igoA: 7.3	1dtlA-3igoA: 17.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EUP_A_ASDA452_1 (CYTOCHROME P450ERYF)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 8	TYR A 188 ILE A 194 LEU A 127 GLU A 123	None	0.90A	1eupA-3igoA: undetectable	1eupA-3igoA: 19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1M8D_A_H4BA902_1 (INDUCIBLE NITRIC OXIDE SYNTHASE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 5	SER A 420 MET A 413 ARG A 356 ILE A 431	None	1.39A	1m8dA-3igoA: 0.0	1m8dA-3igoA: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NSI_A_H4BA600_1 (PROTEIN (NITRIC OXIDE SYNTHASE))	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	ARG A 310 ILE A 301 TRP A 298 PHE A 293	SRT A 543 (-3.8A) None None None	1.08A	1nsiA-3igoA: undetectable 1nsiB-3igoA: undetectable	1nsiA-3igoA: 21.50 1nsiB-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NSI_B_H4BB601_1 (PROTEIN (NITRIC OXIDE SYNTHASE))	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.05A	1nsiA-3igoA: undetectable 1nsiB-3igoA: undetectable	1nsiA-3igoA: 21.50 1nsiB-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NSI_C_H4BC602_1 (PROTEIN (NITRIC OXIDE SYNTHASE))	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	ARG A 310 ILE A 301 TRP A 298 PHE A 293	SRT A 543 (-3.8A) None None None	1.04A	1nsiC-3igoA: undetectable 1nsiD-3igoA: undetectable	1nsiC-3igoA: 21.50 1nsiD-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NSI_D_H4BD603_1 (PROTEIN (NITRIC OXIDE SYNTHASE))	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.05A	1nsiC-3igoA: undetectable 1nsiD-3igoA: undetectable	1nsiC-3igoA: 21.50 1nsiD-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NT2_A_SAMA301_1 (FIBRILLARIN-LIKE PRE-RRNA PROCESSING PROTEIN)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	3 / 3	THR A 156 GLU A 153 ASP A 131	None	0.76A	1nt2A-3igoA: undetectable	1nt2A-3igoA: 19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PXX_A_DIFA701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 10	LEU A 313 GLY A 261 ALA A 260 SER A 259 LEU A 199	None	1.03A	1pxxA-3igoA: undetectable	1pxxA-3igoA: 22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PXX_C_DIFC2701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 12	LEU A 313 GLY A 261 ALA A 260 SER A 259 LEU A 199	None	1.02A	1pxxC-3igoA: undetectable	1pxxC-3igoA: 22.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S8F_A_BEZA1501_0 (RAS-RELATED PROTEIN RAB-9A)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 5	ILE A 309 TRP A 298 LEU A 313 PRO A 273	None	1.21A	1s8fA-3igoA: undetectable 1s8fB-3igoA: undetectable	1s8fA-3igoA: 16.90 1s8fB-3igoA: 16.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 9	LEU A 82 VAL A 90 LYS A 105 LEU A 154 LEU A 222	ANP A 610 ( 4.5A) ANP A 610 (-3.9A) ANP A 610 (-2.8A) GOL A 1 (-4.6A) None	0.80A	1xkkA-3igoA: 21.9	1xkkA-3igoA: 24.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZGY_A_BRLA503_2 (PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 5	ILE A 217 ILE A 332 MET A 189 LEU A 267	None	0.87A	1zgyA-3igoA: 1.0	1zgyA-3igoA: 19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BU8_A_TF4A1379_1 (PYRUVATE DEHYDROGENASE KINASE ISOENZYME 2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 8	LEU A 160 ILE A 263 ILE A 178 ILE A 179	None	0.75A	2bu8A-3igoA: undetectable	2bu8A-3igoA: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IEO_A_017A402_2 (PROTEASE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 12	LEU A 91 ASP A 95 VAL A 151 VAL A 106 VAL A 104	None GOL A 539 (-3.7A) None None None	0.89A	2ieoB-3igoA: undetectable	2ieoB-3igoA: 9.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NSI_A_H4BA600_1 (PROTEIN (NITRIC OXIDE SYNTHASE))	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	ARG A 310 ILE A 301 TRP A 298 PHE A 293	SRT A 543 (-3.8A) None None None	1.06A	2nsiA-3igoA: undetectable 2nsiB-3igoA: undetectable	2nsiA-3igoA: 21.50 2nsiB-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NSI_B_H4BB601_1 (PROTEIN (NITRIC OXIDE SYNTHASE))	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.06A	2nsiA-3igoA: undetectable 2nsiB-3igoA: undetectable	2nsiA-3igoA: 21.50 2nsiB-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NSI_C_H4BC602_1 (PROTEIN (NITRIC OXIDE SYNTHASE))	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	ARG A 310 ILE A 301 TRP A 298 PHE A 293	SRT A 543 (-3.8A) None None None	1.05A	2nsiC-3igoA: undetectable 2nsiD-3igoA: undetectable	2nsiC-3igoA: 21.50 2nsiD-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NSI_D_H4BD603_1 (PROTEIN (NITRIC OXIDE SYNTHASE))	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.06A	2nsiC-3igoA: undetectable 2nsiD-3igoA: undetectable	2nsiC-3igoA: 21.50 2nsiD-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NYR_B_SVRB401_2 (NAD-DEPENDENT DEACETYLASE SIRTUIN-5)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	ARG A 390 GLN A 181 ASN A 134 LEU A 308	None	1.27A	2nyrA-3igoA: undetectable	2nyrA-3igoA: 17.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZW9_B_SAMB801_1 (LEUCINE CARBOXYL METHYLTRANSFERASE 2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 8	ILE A 456 ASP A 131 TYR A 452 SER A 374	None	1.01A	2zw9B-3igoA: undetectable	2zw9B-3igoA: 21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BSZ_E_RTLE177_0 (PLASMA RETINOL-BINDING PROTEIN)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 11	LEU A 442 ALA A 351 ALA A 459 LEU A 370 GLN A 366	None	1.29A	3bszE-3igoA: undetectable	3bszE-3igoA: 17.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CD2_A_MTXA307_1 (DIHYDROFOLATE REDUCTASE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 12	ILE A 179 ILE A 266 PHE A 161 LEU A 160 ILE A 178	None	1.09A	3cd2A-3igoA: undetectable	3cd2A-3igoA: 19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DWJ_B_H4BB902_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 5	SER A 420 MET A 413 ARG A 356 ILE A 431	None	1.49A	3dwjB-3igoA: 0.0	3dwjB-3igoA: 23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3E7G_A_H4BA902_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	ARG A 310 ILE A 301 TRP A 298 PHE A 293	SRT A 543 (-3.8A) None None None	1.07A	3e7gA-3igoA: undetectable 3e7gB-3igoA: undetectable	3e7gA-3igoA: 21.88 3e7gB-3igoA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3E7G_B_H4BB1902_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.07A	3e7gA-3igoA: undetectable 3e7gB-3igoA: undetectable	3e7gA-3igoA: 21.88 3e7gB-3igoA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3E7G_C_H4BC2902_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	ARG A 310 ILE A 301 TRP A 298 PHE A 293	SRT A 543 (-3.8A) None None None	1.07A	3e7gC-3igoA: undetectable 3e7gD-3igoA: undetectable	3e7gC-3igoA: 21.88 3e7gD-3igoA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3E7G_D_H4BD3902_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 8	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.08A	3e7gC-3igoA: undetectable 3e7gD-3igoA: undetectable	3e7gC-3igoA: 21.88 3e7gD-3igoA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EJ8_B_H4BB2902_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.06A	3ej8A-3igoA: undetectable 3ej8B-3igoA: undetectable	3ej8A-3igoA: 21.88 3ej8B-3igoA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EJ8_C_H4BC3902_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	ARG A 310 ILE A 301 TRP A 298 PHE A 293	SRT A 543 (-3.8A) None None None	1.03A	3ej8C-3igoA: 0.0 3ej8D-3igoA: 0.0	3ej8C-3igoA: 21.88 3ej8D-3igoA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EJ8_D_H4BD4902_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.08A	3ej8C-3igoA: 0.0 3ej8D-3igoA: 0.0	3ej8C-3igoA: 21.88 3ej8D-3igoA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EYG_A_MI1A1_1 (TYROSINE-PROTEIN KINASE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	8 / 12	LEU A 82 GLY A 83 GLY A 85 GLY A 88 VAL A 90 ALA A 103 LYS A 105 LEU A 205	ANP A 610 ( 4.5A) ANP A 610 (-3.5A) ANP A 610 (-2.9A) ANP A 610 (-4.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) None	0.64A	3eygA-3igoA: 19.5	3eygA-3igoA: 22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FUP_A_MI1A1_1 (TYROSINE-PROTEIN KINASE JAK2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	8 / 12	LEU A 82 GLY A 83 GLY A 85 GLY A 88 VAL A 90 ALA A 103 LYS A 105 LEU A 205	ANP A 610 ( 4.5A) ANP A 610 (-3.5A) ANP A 610 (-2.9A) ANP A 610 (-4.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) None	0.78A	3fupA-3igoA: 19.6	3fupA-3igoA: 20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HCP_B_CHDB4_0 (FERROCHELATASE, MITOCHONDRIAL)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	3 / 3	GLY A 289 PRO A 273 LEU A 313	None	0.57A	3hcpB-3igoA: undetectable	3hcpB-3igoA: 20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXZ_A_0LIA1_2 (TYROSINE-PROTEIN KINASE ABL1)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 9	LEU A 82 LYS A 105 ILE A 150 ARG A 197 LEU A 205	ANP A 610 ( 4.5A) ANP A 610 (-2.8A) None None None	1.22A	3oxzA-3igoA: 19.5	3oxzA-3igoA: 21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PYY_B_STIB4_2 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 5	VAL A 195 ILE A 217 MET A 399 ARG A 320	None	1.39A	3pyyB-3igoA: 19.8	3pyyB-3igoA: 25.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S56_A_ROCA201_2 (PROTEASE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 9	LEU A 160 GLY A 185 ILE A 186 ILE A 178 ILE A 215	None	0.95A	3s56B-3igoA: undetectable	3s56B-3igoA: 9.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V4T_A_ACTA503_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	3 / 3	ARG A 169 GLU A 172 THR A 300	None	0.86A	3v4tA-3igoA: undetectable	3v4tA-3igoA: 22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_1 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	6 / 12	GLY A 85 GLY A 88 VAL A 90 ALA A 103 LYS A 105 LEU A 205	ANP A 610 (-2.9A) ANP A 610 (-4.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) None	0.77A	3v5wA-3igoA: 10.7	3v5wA-3igoA: 23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CKI_A_ADNA2022_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	6 / 11	LEU A 82 GLY A 83 GLY A 85 VAL A 90 ALA A 103 LEU A 205	ANP A 610 ( 4.5A) ANP A 610 (-3.5A) ANP A 610 (-2.9A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) None	0.78A	4ckiA-3igoA: 20.0	4ckiA-3igoA: 19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4COX_A_IMNA701_1 (CYCLOOXYGENASE-2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 12	LEU A 313 GLY A 261 ALA A 260 SER A 259 LEU A 199	None	1.10A	4coxA-3igoA: undetectable	4coxA-3igoA: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4COX_B_IMNB701_1 (CYCLOOXYGENASE-2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 12	LEU A 313 GLY A 261 ALA A 260 SER A 259 LEU A 199	None	1.11A	4coxB-3igoA: undetectable	4coxB-3igoA: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4COX_D_IMND701_1 (CYCLOOXYGENASE-2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 12	LEU A 313 GLY A 261 ALA A 260 SER A 259 LEU A 199	None	1.10A	4coxD-3igoA: undetectable	4coxD-3igoA: 22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX7_B_H4BB600_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 8	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.05A	4cx7A-3igoA: undetectable 4cx7B-3igoA: undetectable	4cx7A-3igoA: 21.50 4cx7B-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX7_C_H4BC600_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 8	ARG A 310 ILE A 301 TRP A 298 PHE A 293	SRT A 543 (-3.8A) None None None	1.01A	4cx7C-3igoA: 0.0 4cx7D-3igoA: undetectable	4cx7C-3igoA: 21.50 4cx7D-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX7_D_H4BD600_1 (NITRIC OXIDE SYNTHASE, INDUCIBLE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.06A	4cx7C-3igoA: 0.0 4cx7D-3igoA: undetectable	4cx7C-3igoA: 21.50 4cx7D-3igoA: 21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4G19_A_ACTA304_0 (GLUTATHIONE TRANSFERASE GTE1)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 5	ILE A 282 LEU A 283 LYS A 284 ASN A 278	None	0.86A	4g19A-3igoA: undetectable	4g19A-3igoA: 20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4G19_D_ACTD305_0 (GLUTATHIONE TRANSFERASE GTE1)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 4	ILE A 282 LEU A 283 LYS A 284 ASN A 278	None	1.08A	4g19D-3igoA: undetectable	4g19D-3igoA: 20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	8 / 12	ALA A 103 ASP A 162 ASP A 198 LYS A 200 ASN A 203 LEU A 205 ILE A 218 ASP A 219	ANP A 610 ( 3.7A) None None None ANP A 610 ( 4.9A) None ANP A 610 ( 4.4A) ANP A 610 ( 2.7A)	0.77A	4i41A-3igoA: 21.7	4i41A-3igoA: 23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	8 / 12	VAL A 90 ALA A 103 ASP A 198 LYS A 200 ASN A 203 LEU A 205 ILE A 218 ASP A 219	ANP A 610 (-3.9A) ANP A 610 ( 3.7A) None None ANP A 610 ( 4.9A) None ANP A 610 ( 4.4A) ANP A 610 ( 2.7A)	0.65A	4i41A-3igoA: 21.7	4i41A-3igoA: 23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IAA_A_RTZA401_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	6 / 11	VAL A 90 ALA A 103 LYS A 105 LEU A 205 ILE A 218 ASP A 219	ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) None ANP A 610 ( 4.4A) ANP A 610 ( 2.7A)	0.77A	4iaaA-3igoA: 21.8	4iaaA-3igoA: 23.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IFG_A_1E8A601_1 (CALMODULIN-DOMAIN PROTEIN KINASE 1)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	7 / 12	GLY A 83 VAL A 90 ALA A 103 GLY A 158 GLU A 159 LEU A 205 ILE A 218	ANP A 610 (-3.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) None None None ANP A 610 ( 4.4A)	0.41A	4ifgA-3igoA: 29.2	4ifgA-3igoA: 59.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4IFG_A_1E8A601_1 (CALMODULIN-DOMAIN PROTEIN KINASE 1)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	7 / 12	GLY A 83 VAL A 90 ALA A 103 LYS A 105 GLY A 158 LEU A 205 ILE A 218	ANP A 610 (-3.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) None None ANP A 610 ( 4.4A)	0.62A	4ifgA-3igoA: 29.2	4ifgA-3igoA: 59.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_B_8PRB601_1 (RHODOPSIN KINASE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 8	GLY A 85 VAL A 90 ALA A 103 LYS A 105 LEU A 205	ANP A 610 (-2.9A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) None	0.73A	4l9iB-3igoA: 17.3	4l9iB-3igoA: 20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	7 / 12	GLY A 85 VAL A 90 LYS A 105 LEU A 154 GLY A 158 LEU A 205 ASP A 219	ANP A 610 (-2.9A) ANP A 610 (-3.9A) ANP A 610 (-2.8A) GOL A 1 (-4.6A) None None ANP A 610 ( 2.7A)	1.01A	4mkcA-3igoA: 20.7	4mkcA-3igoA: 23.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	7 / 12	LEU A 82 GLY A 85 VAL A 90 LYS A 105 LEU A 154 LEU A 205 ASP A 219	ANP A 610 ( 4.5A) ANP A 610 (-2.9A) ANP A 610 (-3.9A) ANP A 610 (-2.8A) GOL A 1 (-4.6A) None ANP A 610 ( 2.7A)	0.84A	4mkcA-3igoA: 20.7	4mkcA-3igoA: 23.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MKC_A_4MKA1503_1 (ALK TYROSINE KINASE RECEPTOR)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	7 / 12	LEU A 82 VAL A 90 ALA A 103 LYS A 105 LEU A 154 LEU A 205 ASP A 219	ANP A 610 ( 4.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) GOL A 1 (-4.6A) None ANP A 610 ( 2.7A)	0.64A	4mkcA-3igoA: 20.7	4mkcA-3igoA: 23.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NOS_D_H4BD3011_1 (INDUCIBLE NITRIC OXIDE SYNTHASE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	TRP A 298 PHE A 293 ARG A 310 ILE A 301	None None SRT A 543 (-3.8A) None	1.12A	4nosC-3igoA: undetectable 4nosD-3igoA: undetectable	4nosC-3igoA: 21.64 4nosD-3igoA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0S_A_ADNA500_1 (AURORA KINASE A)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	7 / 11	LEU A 82 GLY A 83 VAL A 90 ALA A 103 LYS A 105 ASN A 203 LEU A 205	ANP A 610 ( 4.5A) ANP A 610 (-3.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) ANP A 610 ( 4.9A) None	0.51A	4o0sA-3igoA: 24.9	4o0sA-3igoA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0U_A_ADNA501_1 (AURORA KINASE A)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	VAL A 90 ALA A 103 LYS A 105 LEU A 205	ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) None	0.56A	4o0uA-3igoA: 12.6	4o0uA-3igoA: 24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O0W_A_ADNA501_1 (AURORA KINASE A)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 6	LEU A 82 GLY A 83 VAL A 90 ALA A 103 LEU A 205	ANP A 610 ( 4.5A) ANP A 610 (-3.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) None	0.48A	4o0wA-3igoA: 24.8	4o0wA-3igoA: 24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTI_A_MI1A1001_1 (SERINE/THREONINE-PRO TEIN KINASE N1)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	7 / 12	LEU A 82 GLY A 83 GLY A 85 GLY A 88 VAL A 90 ALA A 103 LEU A 205	ANP A 610 ( 4.5A) ANP A 610 (-3.5A) ANP A 610 (-2.9A) ANP A 610 (-4.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) None	0.48A	4otiA-3igoA: 21.4	4otiA-3igoA: 25.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TYJ_A_0LIA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	LEU A 82 VAL A 90 ILE A 135 ILE A 217	ANP A 610 ( 4.5A) ANP A 610 (-3.9A) None None	0.35A	4tyjA-3igoA: 20.0	4tyjA-3igoA: 20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X1Y_D_LOCD502_2 (TUBULIN BETA CHAIN)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 12	CYH A 326 LEU A 327 LEU A 308 ALA A 260 VAL A 257	None	1.05A	4x1yD-3igoA: undetectable	4x1yD-3igoA: 22.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 12	VAL A 90 ALA A 103 LYS A 105 ASP A 219 PHE A 220	ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) ANP A 610 ( 2.7A) None	0.60A	4xv2A-3igoA: 22.4	4xv2A-3igoA: 25.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FXT_A_0LAA1376_1 (DNA POLYMERASE III SUBUNIT BETA)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	LEU A 313 PRO A 273 ILE A 266 LEU A 267	None	0.98A	5fxtA-3igoA: undetectable	5fxtA-3igoA: 23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H2U_B_1N1B501_1 (PROTEIN-TYROSINE KINASE 6)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	6 / 12	LEU A 82 VAL A 90 ALA A 103 ILE A 150 LEU A 154 LEU A 205	ANP A 610 ( 4.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) None GOL A 1 (-4.6A) None	0.82A	5h2uB-3igoA: 22.6	5h2uB-3igoA: 22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKQ_A_JMSA602_1 (PROSTAGLANDIN G/H SYNTHASE 2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 12	LEU A 313 GLY A 261 ALA A 260 SER A 259 LEU A 199	None	1.04A	5ikqA-3igoA: undetectable	5ikqA-3igoA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 7	GLY A 83 GLY A 85 SER A 86 PHE A 87 GLU A 159	ANP A 610 (-3.5A) ANP A 610 (-2.9A) ANP A 610 (-2.6A) ANP A 610 (-4.7A) None	1.12A	5izfA-3igoA: 22.7	5izfA-3igoA: 25.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	5 / 7	GLY A 85 SER A 86 PHE A 87 LEU A 222 GLU A 159	ANP A 610 (-2.9A) ANP A 610 (-2.6A) ANP A 610 (-4.7A) None None	1.29A	5izfA-3igoA: 22.7	5izfA-3igoA: 25.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	GLY A 83 GLY A 85 SER A 86 GLY A 88	ANP A 610 (-3.5A) ANP A 610 (-2.9A) ANP A 610 (-2.6A) ANP A 610 (-4.5A)	0.28A	5izjB-3igoA: 23.3	5izjB-3igoA: 25.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MAF_A_XINA403_1 (MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	7 / 12	GLY A 83 VAL A 90 ALA A 103 LYS A 105 GLY A 158 GLU A 159 ILE A 218	ANP A 610 (-3.5A) ANP A 610 (-3.9A) ANP A 610 ( 3.7A) ANP A 610 (-2.8A) None None ANP A 610 ( 4.4A)	0.78A	5mafA-3igoA: 25.6	5mafA-3igoA: 12.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MRA_B_DM2B204_1 (SORCIN)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	THR A 386 ARG A 390 ASP A 393 GLY A 398	None None CA A 602 (-3.3A) None	0.67A	5mraA-3igoA: undetectable 5mraB-3igoA: undetectable	5mraA-3igoA: 17.53 5mraB-3igoA: 17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UUN_A_ACTA305_0 (GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	3 / 3	THR A 187 MET A 189 HIS A 192	None	0.99A	5uunA-3igoA: undetectable	5uunA-3igoA: 22.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDH_B_DAHB60_1 (PUTATIVE CYTOCHROME C)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 5	MET A 530 ASN A 537 VAL A 535 LEU A 531	None	1.41A	5xdhB-3igoA: undetectable	5xdhB-3igoA: 9.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDH_C_DAHC60_1 (PUTATIVE CYTOCHROME C)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 6	MET A 530 ASN A 537 VAL A 535 LEU A 531	None	1.10A	5xdhA-3igoA: undetectable 5xdhC-3igoA: undetectable	5xdhA-3igoA: 9.64 5xdhC-3igoA: 9.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDH_D_DAHD60_1 (PUTATIVE CYTOCHROME C)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 5	MET A 530 ASN A 537 VAL A 535 LEU A 531	None	1.42A	5xdhD-3igoA: undetectable	5xdhD-3igoA: 9.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9M_A_NIOA401_1 (CASEIN KINASE II SUBUNIT ALPHA')	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 8	VAL A 90 LYS A 105 ILE A 218 ASP A 219	ANP A 610 (-3.9A) ANP A 610 (-2.8A) ANP A 610 ( 4.4A) ANP A 610 ( 2.7A)	0.70A	5y9mA-3igoA: 20.3	5y9mA-3igoA: 8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_B_NIOB401_1 (CASEIN KINASE II SUBUNIT ALPHA')	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	VAL A 90 LYS A 105 ILE A 218 ASP A 219	ANP A 610 (-3.9A) ANP A 610 (-2.8A) ANP A 610 ( 4.4A) ANP A 610 ( 2.7A)	0.84A	5yf9B-3igoA: 20.1	5yf9B-3igoA: 8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YWM_X_NIOX403_0 (CASEIN KINASE II SUBUNIT ALPHA')	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	VAL A 90 LYS A 105 ILE A 218 ASP A 219	ANP A 610 (-3.9A) ANP A 610 (-2.8A) ANP A 610 ( 4.4A) ANP A 610 ( 2.7A)	0.68A	5ywmX-3igoA: 14.8	5ywmX-3igoA: 8.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CDU_G_EY4G501_0 (CHIMERIC ALPHA1GABAA RECEPTOR)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 7	ILE A 178 GLN A 181 VAL A 182 ILE A 263	None	0.87A	6cduF-3igoA: undetectable 6cduG-3igoA: undetectable	6cduF-3igoA: 20.08 6cduG-3igoA: 20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CDU_G_EY4G502_0 (CHIMERIC ALPHA1GABAA RECEPTOR)	3igo	CALMODULIN-DOMAIN PROTEIN KINASE 1 (Cryptosporidium parvum)	4 / 8	ILE A 178 GLN A 181 VAL A 182 ILE A 263	None	1.03A	6cduG-3igoA: undetectable 6cduH-3igoA: undetectable	6cduG-3igoA: 20.08 6cduH-3igoA: 20.08

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DTL_A_BEPA204_1","CARDIAC TROPONIN C","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"ILE A 186;LEU A 199;LEU A 160;LEU A 268;LEU A 267","None","1.05A","1dtlA-3igoA:7.3","1dtlA-3igoA:17.86"],["1EUP_A_ASDA452_1","CYTOCHROME P450ERYF","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TYR A 188;ILE A 194;LEU A 127;GLU A 123","None","0.90A","1eupA-3igoA:undetectable","1eupA-3igoA:19.43"],["1M8D_A_H4BA902_1","INDUCIBLE NITRIC OXIDE SYNTHASE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"SER A 420;MET A 413;ARG A 356;ILE A 431","None","1.39A","1m8dA-3igoA:0.0","1m8dA-3igoA:22.84"],["1NSI_A_H4BA600_1","PROTEIN (NITRIC OXIDE SYNTHASE);PROTEIN (NITRIC OXIDE SYNTHASE)","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ARG A 310;ILE A 301;TRP A 298;PHE A 293","SRT A 543 (-3.8A);None;None;None","1.08A","1nsiA-3igoA:undetectable;1nsiB-3igoA:undetectable","1nsiA-3igoA:21.50;1nsiB-3igoA:21.50"],["1NSI_B_H4BB601_1","PROTEIN (NITRIC OXIDE SYNTHASE);PROTEIN (NITRIC OXIDE SYNTHASE)","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.05A","1nsiA-3igoA:undetectable;1nsiB-3igoA:undetectable","1nsiA-3igoA:21.50;1nsiB-3igoA:21.50"],["1NSI_C_H4BC602_1","PROTEIN (NITRIC OXIDE SYNTHASE);PROTEIN (NITRIC OXIDE SYNTHASE)","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ARG A 310;ILE A 301;TRP A 298;PHE A 293","SRT A 543 (-3.8A);None;None;None","1.04A","1nsiC-3igoA:undetectable;1nsiD-3igoA:undetectable","1nsiC-3igoA:21.50;1nsiD-3igoA:21.50"],["1NSI_D_H4BD603_1","PROTEIN (NITRIC OXIDE SYNTHASE);PROTEIN (NITRIC OXIDE SYNTHASE)","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.05A","1nsiC-3igoA:undetectable;1nsiD-3igoA:undetectable","1nsiC-3igoA:21.50;1nsiD-3igoA:21.50"],["1NT2_A_SAMA301_1","FIBRILLARIN-LIKE PRE-RRNA PROCESSING PROTEIN","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",3,"THR A 156;GLU A 153;ASP A 131","None","0.76A","1nt2A-3igoA:undetectable","1nt2A-3igoA:19.67"],["1PXX_A_DIFA701_1","PROSTAGLANDIN G\/H SYNTHASE 2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A 313;GLY A 261;ALA A 260;SER A 259;LEU A 199","None","1.03A","1pxxA-3igoA:undetectable","1pxxA-3igoA:22.78"],["1PXX_C_DIFC2701_1","PROSTAGLANDIN G\/H SYNTHASE 2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A 313;GLY A 261;ALA A 260;SER A 259;LEU A 199","None","1.02A","1pxxC-3igoA:undetectable","1pxxC-3igoA:22.78"],["1S8F_A_BEZA1501_0","RAS-RELATED PROTEIN RAB-9A","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ILE A 309;TRP A 298;LEU A 313;PRO A 273","None","1.21A","1s8fA-3igoA:undetectable;1s8fB-3igoA:undetectable","1s8fA-3igoA:16.90;1s8fB-3igoA:16.90"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A  82;VAL A  90;LYS A 105;LEU A 154;LEU A 222","ANP A 610 ( 4.5A);ANP A 610 (-3.9A);ANP A 610 (-2.8A);GOL A   1 (-4.6A);None","0.80A","1xkkA-3igoA:21.9","1xkkA-3igoA:24.42"],["1ZGY_A_BRLA503_2","PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ILE A 217;ILE A 332;MET A 189;LEU A 267","None","0.87A","1zgyA-3igoA:1.0","1zgyA-3igoA:19.92"],["2BU8_A_TF4A1379_1","PYRUVATE DEHYDROGENASE KINASE ISOENZYME 2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"LEU A 160;ILE A 263;ILE A 178;ILE A 179","None","0.75A","2bu8A-3igoA:undetectable","2bu8A-3igoA:21.89"],["2IEO_A_017A402_2","PROTEASE;PROTEASE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A  91;ASP A  95;VAL A 151;VAL A 106;VAL A 104","None;GOL A 539 (-3.7A);None;None;None","0.89A","2ieoB-3igoA:undetectable","2ieoB-3igoA:9.75"],["2NSI_A_H4BA600_1","PROTEIN (NITRIC OXIDE SYNTHASE);PROTEIN (NITRIC OXIDE SYNTHASE)","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ARG A 310;ILE A 301;TRP A 298;PHE A 293","SRT A 543 (-3.8A);None;None;None","1.06A","2nsiA-3igoA:undetectable;2nsiB-3igoA:undetectable","2nsiA-3igoA:21.50;2nsiB-3igoA:21.50"],["2NSI_B_H4BB601_1","PROTEIN (NITRIC OXIDE SYNTHASE);PROTEIN (NITRIC OXIDE SYNTHASE)","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.06A","2nsiA-3igoA:undetectable;2nsiB-3igoA:undetectable","2nsiA-3igoA:21.50;2nsiB-3igoA:21.50"],["2NSI_C_H4BC602_1","PROTEIN (NITRIC OXIDE SYNTHASE);PROTEIN (NITRIC OXIDE SYNTHASE)","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ARG A 310;ILE A 301;TRP A 298;PHE A 293","SRT A 543 (-3.8A);None;None;None","1.05A","2nsiC-3igoA:undetectable;2nsiD-3igoA:undetectable","2nsiC-3igoA:21.50;2nsiD-3igoA:21.50"],["2NSI_D_H4BD603_1","PROTEIN (NITRIC OXIDE SYNTHASE);PROTEIN (NITRIC OXIDE SYNTHASE)","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.06A","2nsiC-3igoA:undetectable;2nsiD-3igoA:undetectable","2nsiC-3igoA:21.50;2nsiD-3igoA:21.50"],["2NYR_B_SVRB401_2","NAD-DEPENDENT DEACETYLASE SIRTUIN-5;NAD-DEPENDENT DEACETYLASE SIRTUIN-5","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ARG A 390;GLN A 181;ASN A 134;LEU A 308","None","1.27A","2nyrA-3igoA:undetectable","2nyrA-3igoA:17.73"],["2ZW9_B_SAMB801_1","LEUCINE CARBOXYL METHYLTRANSFERASE 2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ILE A 456;ASP A 131;TYR A 452;SER A 374","None","1.01A","2zw9B-3igoA:undetectable","2zw9B-3igoA:21.26"],["3BSZ_E_RTLE177_0","PLASMA RETINOL-BINDING PROTEIN","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A 442;ALA A 351;ALA A 459;LEU A 370;GLN A 366","None","1.29A","3bszE-3igoA:undetectable","3bszE-3igoA:17.92"],["3CD2_A_MTXA307_1","DIHYDROFOLATE REDUCTASE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"ILE A 179;ILE A 266;PHE A 161;LEU A 160;ILE A 178","None","1.09A","3cd2A-3igoA:undetectable","3cd2A-3igoA:19.10"],["3DWJ_B_H4BB902_1","NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"SER A 420;MET A 413;ARG A 356;ILE A 431","None","1.49A","3dwjB-3igoA:0.0","3dwjB-3igoA:23.36"],["3E7G_A_H4BA902_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ARG A 310;ILE A 301;TRP A 298;PHE A 293","SRT A 543 (-3.8A);None;None;None","1.07A","3e7gA-3igoA:undetectable;3e7gB-3igoA:undetectable","3e7gA-3igoA:21.88;3e7gB-3igoA:21.88"],["3E7G_B_H4BB1902_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.07A","3e7gA-3igoA:undetectable;3e7gB-3igoA:undetectable","3e7gA-3igoA:21.88;3e7gB-3igoA:21.88"],["3E7G_C_H4BC2902_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ARG A 310;ILE A 301;TRP A 298;PHE A 293","SRT A 543 (-3.8A);None;None;None","1.07A","3e7gC-3igoA:undetectable;3e7gD-3igoA:undetectable","3e7gC-3igoA:21.88;3e7gD-3igoA:21.88"],["3E7G_D_H4BD3902_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.08A","3e7gC-3igoA:undetectable;3e7gD-3igoA:undetectable","3e7gC-3igoA:21.88;3e7gD-3igoA:21.88"],["3EJ8_B_H4BB2902_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.06A","3ej8A-3igoA:undetectable;3ej8B-3igoA:undetectable","3ej8A-3igoA:21.88;3ej8B-3igoA:21.88"],["3EJ8_C_H4BC3902_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ARG A 310;ILE A 301;TRP A 298;PHE A 293","SRT A 543 (-3.8A);None;None;None","1.03A","3ej8C-3igoA:0.0;3ej8D-3igoA:0.0","3ej8C-3igoA:21.88;3ej8D-3igoA:21.88"],["3EJ8_D_H4BD4902_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.08A","3ej8C-3igoA:0.0;3ej8D-3igoA:0.0","3ej8C-3igoA:21.88;3ej8D-3igoA:21.88"],["3EYG_A_MI1A1_1","TYROSINE-PROTEIN KINASE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",8,"LEU A  82;GLY A  83;GLY A  85;GLY A  88;VAL A  90;ALA A 103;LYS A 105;LEU A 205","ANP A 610 ( 4.5A);ANP A 610 (-3.5A);ANP A 610 (-2.9A);ANP A 610 (-4.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);None","0.64A","3eygA-3igoA:19.5","3eygA-3igoA:22.74"],["3FUP_A_MI1A1_1","TYROSINE-PROTEIN KINASE JAK2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",8,"LEU A  82;GLY A  83;GLY A  85;GLY A  88;VAL A  90;ALA A 103;LYS A 105;LEU A 205","ANP A 610 ( 4.5A);ANP A 610 (-3.5A);ANP A 610 (-2.9A);ANP A 610 (-4.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);None","0.78A","3fupA-3igoA:19.6","3fupA-3igoA:20.83"],["3HCP_B_CHDB4_0","FERROCHELATASE, MITOCHONDRIAL","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",3,"GLY A 289;PRO A 273;LEU A 313","None","0.57A","3hcpB-3igoA:undetectable","3hcpB-3igoA:20.65"],["3OXZ_A_0LIA1_2","TYROSINE-PROTEIN KINASE ABL1","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A  82;LYS A 105;ILE A 150;ARG A 197;LEU A 205","ANP A 610 ( 4.5A);ANP A 610 (-2.8A);None;None;None","1.22A","3oxzA-3igoA:19.5","3oxzA-3igoA:21.65"],["3PYY_B_STIB4_2","V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"VAL A 195;ILE A 217;MET A 399;ARG A 320","None","1.39A","3pyyB-3igoA:19.8","3pyyB-3igoA:25.43"],["3S56_A_ROCA201_2","PROTEASE;PROTEASE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A 160;GLY A 185;ILE A 186;ILE A 178;ILE A 215","None","0.95A","3s56B-3igoA:undetectable","3s56B-3igoA:9.75"],["3V4T_A_ACTA503_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",3,"ARG A 169;GLU A 172;THR A 300","None","0.86A","3v4tA-3igoA:undetectable","3v4tA-3igoA:22.57"],["3V5W_A_8PRA701_1","G-PROTEIN COUPLED RECEPTOR KINASE 2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",6,"GLY A  85;GLY A  88;VAL A  90;ALA A 103;LYS A 105;LEU A 205","ANP A 610 (-2.9A);ANP A 610 (-4.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);None","0.77A","3v5wA-3igoA:10.7","3v5wA-3igoA:23.56"],["4CKI_A_ADNA2022_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",6,"LEU A  82;GLY A  83;GLY A  85;VAL A  90;ALA A 103;LEU A 205","ANP A 610 ( 4.5A);ANP A 610 (-3.5A);ANP A 610 (-2.9A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);None","0.78A","4ckiA-3igoA:20.0","4ckiA-3igoA:19.85"],["4COX_A_IMNA701_1","CYCLOOXYGENASE-2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A 313;GLY A 261;ALA A 260;SER A 259;LEU A 199","None","1.10A","4coxA-3igoA:undetectable","4coxA-3igoA:22.67"],["4COX_B_IMNB701_1","CYCLOOXYGENASE-2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A 313;GLY A 261;ALA A 260;SER A 259;LEU A 199","None","1.11A","4coxB-3igoA:undetectable","4coxB-3igoA:22.67"],["4COX_D_IMND701_1","CYCLOOXYGENASE-2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A 313;GLY A 261;ALA A 260;SER A 259;LEU A 199","None","1.10A","4coxD-3igoA:undetectable","4coxD-3igoA:22.67"],["4CX7_B_H4BB600_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.05A","4cx7A-3igoA:undetectable;4cx7B-3igoA:undetectable","4cx7A-3igoA:21.50;4cx7B-3igoA:21.50"],["4CX7_C_H4BC600_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ARG A 310;ILE A 301;TRP A 298;PHE A 293","SRT A 543 (-3.8A);None;None;None","1.01A","4cx7C-3igoA:0.0;4cx7D-3igoA:undetectable","4cx7C-3igoA:21.50;4cx7D-3igoA:21.50"],["4CX7_D_H4BD600_1","NITRIC OXIDE SYNTHASE, INDUCIBLE;NITRIC OXIDE SYNTHASE, INDUCIBLE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.06A","4cx7C-3igoA:0.0;4cx7D-3igoA:undetectable","4cx7C-3igoA:21.50;4cx7D-3igoA:21.50"],["4G19_A_ACTA304_0","GLUTATHIONE TRANSFERASE GTE1","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ILE A 282;LEU A 283;LYS A 284;ASN A 278","None","0.86A","4g19A-3igoA:undetectable","4g19A-3igoA:20.13"],["4G19_D_ACTD305_0","GLUTATHIONE TRANSFERASE GTE1","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ILE A 282;LEU A 283;LYS A 284;ASN A 278","None","1.08A","4g19D-3igoA:undetectable","4g19D-3igoA:20.13"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",8,"ALA A 103;ASP A 162;ASP A 198;LYS A 200;ASN A 203;LEU A 205;ILE A 218;ASP A 219","ANP A 610 ( 3.7A);None;None;None;ANP A 610 ( 4.9A);None;ANP A 610 ( 4.4A);ANP A 610 ( 2.7A)","0.77A","4i41A-3igoA:21.7","4i41A-3igoA:23.47"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",8,"VAL A  90;ALA A 103;ASP A 198;LYS A 200;ASN A 203;LEU A 205;ILE A 218;ASP A 219","ANP A 610 (-3.9A);ANP A 610 ( 3.7A);None;None;ANP A 610 ( 4.9A);None;ANP A 610 ( 4.4A);ANP A 610 ( 2.7A)","0.65A","4i41A-3igoA:21.7","4i41A-3igoA:23.47"],["4IAA_A_RTZA401_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",6,"VAL A  90;ALA A 103;LYS A 105;LEU A 205;ILE A 218;ASP A 219","ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);None;ANP A 610 ( 4.4A);ANP A 610 ( 2.7A)","0.77A","4iaaA-3igoA:21.8","4iaaA-3igoA:23.20"],["4IFG_A_1E8A601_1","CALMODULIN-DOMAIN PROTEIN KINASE 1","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",7,"GLY A  83;VAL A  90;ALA A 103;GLY A 158;GLU A 159;LEU A 205;ILE A 218","ANP A 610 (-3.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);None;None;None;ANP A 610 ( 4.4A)","0.41A","4ifgA-3igoA:29.2","4ifgA-3igoA:59.69"],["4IFG_A_1E8A601_1","CALMODULIN-DOMAIN PROTEIN KINASE 1","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",7,"GLY A  83;VAL A  90;ALA A 103;LYS A 105;GLY A 158;LEU A 205;ILE A 218","ANP A 610 (-3.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);None;None;ANP A 610 ( 4.4A)","0.62A","4ifgA-3igoA:29.2","4ifgA-3igoA:59.69"],["4L9I_B_8PRB601_1","RHODOPSIN KINASE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"GLY A  85;VAL A  90;ALA A 103;LYS A 105;LEU A 205","ANP A 610 (-2.9A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);None","0.73A","4l9iB-3igoA:17.3","4l9iB-3igoA:20.92"],["4MKC_A_4MKA1503_1","ALK TYROSINE KINASE RECEPTOR","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",7,"GLY A  85;VAL A  90;LYS A 105;LEU A 154;GLY A 158;LEU A 205;ASP A 219","ANP A 610 (-2.9A);ANP A 610 (-3.9A);ANP A 610 (-2.8A);GOL A   1 (-4.6A);None;None;ANP A 610 ( 2.7A)","1.01A","4mkcA-3igoA:20.7","4mkcA-3igoA:23.22"],["4MKC_A_4MKA1503_1","ALK TYROSINE KINASE RECEPTOR","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",7,"LEU A  82;GLY A  85;VAL A  90;LYS A 105;LEU A 154;LEU A 205;ASP A 219","ANP A 610 ( 4.5A);ANP A 610 (-2.9A);ANP A 610 (-3.9A);ANP A 610 (-2.8A);GOL A   1 (-4.6A);None;ANP A 610 ( 2.7A)","0.84A","4mkcA-3igoA:20.7","4mkcA-3igoA:23.22"],["4MKC_A_4MKA1503_1","ALK TYROSINE KINASE RECEPTOR","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",7,"LEU A  82;VAL A  90;ALA A 103;LYS A 105;LEU A 154;LEU A 205;ASP A 219","ANP A 610 ( 4.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);GOL A   1 (-4.6A);None;ANP A 610 ( 2.7A)","0.64A","4mkcA-3igoA:20.7","4mkcA-3igoA:23.22"],["4NOS_D_H4BD3011_1","INDUCIBLE NITRIC OXIDE SYNTHASE;INDUCIBLE NITRIC OXIDE SYNTHASE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"TRP A 298;PHE A 293;ARG A 310;ILE A 301","None;None;SRT A 543 (-3.8A);None","1.12A","4nosC-3igoA:undetectable;4nosD-3igoA:undetectable","4nosC-3igoA:21.64;4nosD-3igoA:21.64"],["4O0S_A_ADNA500_1","AURORA KINASE A","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",7,"LEU A  82;GLY A  83;VAL A  90;ALA A 103;LYS A 105;ASN A 203;LEU A 205","ANP A 610 ( 4.5A);ANP A 610 (-3.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);ANP A 610 ( 4.9A);None","0.51A","4o0sA-3igoA:24.9","4o0sA-3igoA:25.00"],["4O0U_A_ADNA501_1","AURORA KINASE A","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"VAL A  90;ALA A 103;LYS A 105;LEU A 205","ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);None","0.56A","4o0uA-3igoA:12.6","4o0uA-3igoA:24.77"],["4O0W_A_ADNA501_1","AURORA KINASE A","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A  82;GLY A  83;VAL A  90;ALA A 103;LEU A 205","ANP A 610 ( 4.5A);ANP A 610 (-3.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);None","0.48A","4o0wA-3igoA:24.8","4o0wA-3igoA:24.77"],["4OTI_A_MI1A1001_1","SERINE\/THREONINE-PROTEIN KINASE N1","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",7,"LEU A  82;GLY A  83;GLY A  85;GLY A  88;VAL A  90;ALA A 103;LEU A 205","ANP A 610 ( 4.5A);ANP A 610 (-3.5A);ANP A 610 (-2.9A);ANP A 610 (-4.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);None","0.48A","4otiA-3igoA:21.4","4otiA-3igoA:25.86"],["4TYJ_A_0LIA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"LEU A  82;VAL A  90;ILE A 135;ILE A 217","ANP A 610 ( 4.5A);ANP A 610 (-3.9A);None;None","0.35A","4tyjA-3igoA:20.0","4tyjA-3igoA:20.08"],["4X1Y_D_LOCD502_2","TUBULIN BETA CHAIN","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"CYH A 326;LEU A 327;LEU A 308;ALA A 260;VAL A 257","None","1.05A","4x1yD-3igoA:undetectable","4x1yD-3igoA:22.27"],["4XV2_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"VAL A  90;ALA A 103;LYS A 105;ASP A 219;PHE A 220","ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);ANP A 610 ( 2.7A);None","0.60A","4xv2A-3igoA:22.4","4xv2A-3igoA:25.11"],["5FXT_A_0LAA1376_1","DNA POLYMERASE III SUBUNIT BETA","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"LEU A 313;PRO A 273;ILE A 266;LEU A 267","None","0.98A","5fxtA-3igoA:undetectable","5fxtA-3igoA:23.26"],["5H2U_B_1N1B501_1","PROTEIN-TYROSINE KINASE 6","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",6,"LEU A  82;VAL A  90;ALA A 103;ILE A 150;LEU A 154;LEU A 205","ANP A 610 ( 4.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);None;GOL A   1 (-4.6A);None","0.82A","5h2uB-3igoA:22.6","5h2uB-3igoA:22.20"],["5IKQ_A_JMSA602_1","PROSTAGLANDIN G\/H SYNTHASE 2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"LEU A 313;GLY A 261;ALA A 260;SER A 259;LEU A 199","None","1.04A","5ikqA-3igoA:undetectable","5ikqA-3igoA:20.35"],["5IZF_E_AZ1E2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;6J9-ZEU-DAR-ACA-DAR-NH2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"GLY A  83;GLY A  85;SER A  86;PHE A  87;GLU A 159","ANP A 610 (-3.5A);ANP A 610 (-2.9A);ANP A 610 (-2.6A);ANP A 610 (-4.7A);None","1.12A","5izfA-3igoA:22.7","5izfA-3igoA:25.39"],["5IZF_E_AZ1E2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;6J9-ZEU-DAR-ACA-DAR-NH2","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",5,"GLY A  85;SER A  86;PHE A  87;LEU A 222;GLU A 159","ANP A 610 (-2.9A);ANP A 610 (-2.6A);ANP A 610 (-4.7A);None;None","1.29A","5izfA-3igoA:22.7","5izfA-3igoA:25.39"],["5IZJ_F_AZ1F2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR-DAR","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"GLY A  83;GLY A  85;SER A  86;GLY A  88","ANP A 610 (-3.5A);ANP A 610 (-2.9A);ANP A 610 (-2.6A);ANP A 610 (-4.5A)","0.28A","5izjB-3igoA:23.3","5izjB-3igoA:25.39"],["5MAF_A_XINA403_1","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",7,"GLY A  83;VAL A  90;ALA A 103;LYS A 105;GLY A 158;GLU A 159;ILE A 218","ANP A 610 (-3.5A);ANP A 610 (-3.9A);ANP A 610 ( 3.7A);ANP A 610 (-2.8A);None;None;ANP A 610 ( 4.4A)","0.78A","5mafA-3igoA:25.6","5mafA-3igoA:12.35"],["5MRA_B_DM2B204_1","SORCIN;SORCIN","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"THR A 386;ARG A 390;ASP A 393;GLY A 398","None;None; CA A 602 (-3.3A);None","0.67A","5mraA-3igoA:undetectable;5mraB-3igoA:undetectable","5mraA-3igoA:17.53;5mraB-3igoA:17.53"],["5UUN_A_ACTA305_0","GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",3,"THR A 187;MET A 189;HIS A 192","None","0.99A","5uunA-3igoA:undetectable","5uunA-3igoA:22.63"],["5XDH_B_DAHB60_1","PUTATIVE CYTOCHROME C","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"MET A 530;ASN A 537;VAL A 535;LEU A 531","None","1.41A","5xdhB-3igoA:undetectable","5xdhB-3igoA:9.64"],["5XDH_C_DAHC60_1","PUTATIVE CYTOCHROME C;PUTATIVE CYTOCHROME C","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"MET A 530;ASN A 537;VAL A 535;LEU A 531","None","1.10A","5xdhA-3igoA:undetectable;5xdhC-3igoA:undetectable","5xdhA-3igoA:9.64;5xdhC-3igoA:9.64"],["5XDH_D_DAHD60_1","PUTATIVE CYTOCHROME C","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"MET A 530;ASN A 537;VAL A 535;LEU A 531","None","1.42A","5xdhD-3igoA:undetectable","5xdhD-3igoA:9.64"],["5Y9M_A_NIOA401_1","CASEIN KINASE II SUBUNIT ALPHA'","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"VAL A  90;LYS A 105;ILE A 218;ASP A 219","ANP A 610 (-3.9A);ANP A 610 (-2.8A);ANP A 610 ( 4.4A);ANP A 610 ( 2.7A)","0.70A","5y9mA-3igoA:20.3","5y9mA-3igoA:8.39"],["5YF9_B_NIOB401_1","CASEIN KINASE II SUBUNIT ALPHA'","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"VAL A  90;LYS A 105;ILE A 218;ASP A 219","ANP A 610 (-3.9A);ANP A 610 (-2.8A);ANP A 610 ( 4.4A);ANP A 610 ( 2.7A)","0.84A","5yf9B-3igoA:20.1","5yf9B-3igoA:8.39"],["5YWM_X_NIOX403_0","CASEIN KINASE II SUBUNIT ALPHA'","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"VAL A  90;LYS A 105;ILE A 218;ASP A 219","ANP A 610 (-3.9A);ANP A 610 (-2.8A);ANP A 610 ( 4.4A);ANP A 610 ( 2.7A)","0.68A","5ywmX-3igoA:14.8","5ywmX-3igoA:8.39"],["6CDU_G_EY4G501_0","CHIMERIC ALPHA1GABAA RECEPTOR","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ILE A 178;GLN A 181;VAL A 182;ILE A 263","None","0.87A","6cduF-3igoA:undetectable;6cduG-3igoA:undetectable","6cduF-3igoA:20.08;6cduG-3igoA:20.08"],["6CDU_G_EY4G502_0","CHIMERIC ALPHA1GABAA RECEPTOR","3igo","CALMODULIN-DOMAIN PROTEIN KINASE 1","Cryptosporidium parvum",4,"ILE A 178;GLN A 181;VAL A 182;ILE A 263","None","1.03A","6cduG-3igoA:undetectable;6cduH-3igoA:undetectable","6cduG-3igoA:20.08;6cduH-3igoA:20.08"]]